Seasoned biotech veteran launches new company: "This will be so much fun"

At the turn of his 65th year, experienced biotech veteran Peter Nordkild is still up for an adventure. He and two colleagues have founded a new Danish biotech company which will develop drugs for the treatment of a long list of common ailments, and eventually multiresistant viruses and bacteria.

Photo: Asarina Pharma / PR

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try MedWatch for 14 days.

Get a trial subscription here.

Do you want a trial subscription with multiple users for yourself and your colleagues?

Read more about your options and find the contact information to our sales team here.

Related articles